Allan Urry investigates how criminal syndicates have been able to target GPs, hospitals and chemists with cheap counterfeit drugs. With the NHS under pressure to cut its 11 billion-pound annual spending on medicines, has the hunt for cheaper alternatives opened the door to these dangerous fakes?